FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Acetazolamide Injection
Status: Currently in Shortage
»Date first posted: 12/02/2020
»Therapeutic Categories: Cardiovascular; Ophthalmology

Expand all

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/08/2021)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg per vial (NDC 0143-9503-01) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing and will be available in the April - May 2021 timeframe. Product will be made available as it is released. Demand increase for the drug

Mylan Institutional, a Viatris company (Reverified 05/11/2021)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, Lyophilisate in Single Dose Vials 1PK (NDC 67457-853-50) Available Demand increase for the drug

X-GEN Pharmaceuticals, Inc. (Reverified 03/01/2021)

Company Contact Information:
866-390-4411

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500mg per vial (NDC 39822-0190-1) Not available until April 2021. Continued capacity constraints at manufacturer. Delay in manufacturing/shipping of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English